| Financial Year |
March 31 2023 |
| Monetary Funds |
330,153,079.39 |
| Held-for-trading Financial Assets |
72,662,077.58 |
| Notes Receivable |
3,009,542.17 |
| Accounts Receivable |
524,522,960.08 |
| Advances to Suppliers |
13,624,031.10 |
| Other Receivables |
28,475,183.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
185,302,705.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,135,959.17 |
| Total Current Assets |
1,173,885,538.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,703,791.86 |
| Investment Properties |
28,776,900.43 |
| Fixed Assetes |
327,281,071.34 |
| Under-construction Projects |
1,756,144.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
80,621,096.04 |
| R&D expenses |
-- |
| Goodwill |
248,642.27 |
| Long-Term Deferred and Prepaid Expenses |
7,121,545.40 |
| Deferred Income Tax Assets |
21,824,914.36 |
| Other Non-Current Assets |
138,100,137.69 |
| Sub-Total of Non-Current Assets |
634,824,449.40 |
| Total Assets |
1,808,709,988.00 |
| Short-Term Loans |
338,800,000.00 |
| Trading Financial liabilities |
5,686,666.40 |
| Notes Payable |
5,930,000.00 |
| Accounts Payable |
349,079,668.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,210,659.44 |
| Taxes Payable |
16,788,978.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,633,293.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
63,419,970.07 |
| Other Current Liabilities |
218,050.30 |
| Sub-Total of Current Liabilities |
860,829,381.85 |
| Long-term Loans |
125,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
137,230,984.38 |
| Total Liabilities |
998,060,366.23 |
| Paid-In Capital(Or Share Stock) |
534,272,953.00 |
| Capital Surplus |
676,093,046.09 |
| Surplus Reserve |
62,250,337.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-465,190,598.66 |
| Minority Stockholder's Interest |
978,904.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
809,670,717.66 |
| Owner's Equity（Stockholder's Equity） |
810,649,621.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,808,709,988.00 |
